Would it be flip of me to say, “A whole bunch of stuff?” It’s one of the main reasons I was attracted to the practice in the ...

Traditional medications are synthesized through chemical reactions, whereas biologics are derived from and reproduced, at ...

Investigators who designed a base-editing treatment are planning an "umbrella of umbrellas" trial, while others are developing roadmaps to guide personalized treatments.

A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel ...

A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine ...

The study shows lung and skin cancer patients who were undergoing a type of immunotherapy and who happened to get the COVID ...

Q: My doctor just told me that I’m now considered obese. A week ago, I wasn’t — and I haven’t gained any weight. What’s going ...

For the quarter ended September 2025, Moderna (MRNA) reported revenue of $1.02 billion, down 45.4% over the same period last year. EPS came in at -$0.51, compared to $0.03 in the year-ago quarter. The ...

Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have ...

A new lipid nanoparticle could make mRNA vaccines more effective and potentially lower the cost per dose. New research suggests an mRNA influenza vaccine delivered with the new particle could generate ...

Moderna posts a smaller Q3 loss, trims 2025 sales forecast, cuts R&D costs, and boosts cash outlook as COVID vaccine demand ...